{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:30:10Z","timestamp":1762507810229,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s11239-019-01923-9","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T07:02:53Z","timestamp":1564988573000},"page":"42-53","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9227-0360","authenticated-orcid":false,"given":"Vincenzo","family":"Russo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Attena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Di Maio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreina","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Rago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"D\u2019Onofrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Golino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"issue":"18","key":"1923_CR1","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"AS Go","year":"2001","unstructured":"Go AS, Hylek EM, Phillips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285(18):2370\u20132375","journal-title":"JAMA"},{"issue":"2","key":"1923_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263\u2013272","journal-title":"Chest"},{"issue":"5","key":"1923_CR3","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138(5):1093\u20131100","journal-title":"Chest"},{"issue":"11","key":"1923_CR4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2165\/00002512-200219110-00002","volume":"19","author":"G Chatap","year":"2002","unstructured":"Chatap G, Giraud K, Vincent JP (2002) Atrial fibrillation in the elderly: facts and management. Drugs Aging 19(11):819\u2013846","journal-title":"Drugs Aging"},{"issue":"38","key":"1923_CR5","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37(38):2893\u20132962","journal-title":"Eur Heart J"},{"issue":"5","key":"1923_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/jgs.12799","volume":"62","author":"P Sardar","year":"2014","unstructured":"Sardar P, Chatterjee S, Chaudhari S, Lip GY (2014) New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials. J Am Geriatr Soc 62(5):857\u2013864","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"1923_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2459\/JCM.0000000000000744","volume":"20","author":"P Verdecchia","year":"2019","unstructured":"Verdecchia P, D'Onofrio A, Russo V et al (2019) Persistence on apixaban in atrial fibrillation patients: a retrospective multicentre study. J Cardiovasc Med 20(2):66\u201373","journal-title":"J Cardiovasc Med"},{"issue":"11","key":"1923_CR8","doi-asserted-by":"publisher","first-page":"922","DOI":"10.2459\/JCM.0000000000000548","volume":"18","author":"V Russo","year":"2017","unstructured":"Russo V, Rago A, D'Onofrio A, Nigro G (2017) The clinical performance of dabigatran in the Italian real-life experience. J Cardiovasc Med 18(11):922\u2013923","journal-title":"J Cardiovasc Med"},{"issue":"4","key":"1923_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/FJC.0000000000000661","volume":"73","author":"V Russo","year":"2019","unstructured":"Russo V, Carbone A, Rago A, Golino P, Nigro G (2019) Direct oral anticoagulants in octogenarians with atrial fibrillation: it is never too late. J Cardiovasc Pharmacol 73(4):207\u2013214","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"1923_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","volume":"151","author":"DE Singer","year":"2009","unstructured":"Singer DE, Chang Y, Fang MC et al (2009) The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 151(5):297\u2013305","journal-title":"Ann Intern Med"},{"issue":"11","key":"1923_CR11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jacc.2010.05.028","volume":"56","author":"R Marinigh","year":"2010","unstructured":"Marinigh R, Lip GY, Fiotti N, Giansante C, Lane DA (2010) Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. J Am Coll Cardiol 56(11):827\u2013837","journal-title":"J Am Coll Cardiol"},{"issue":"46","key":"1923_CR12","first-page":"3238","volume":"36","author":"F Andreotti","year":"2015","unstructured":"Andreotti F, Rocca B, Husted S et al (2015) Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J 36(46):3238\u20133249","journal-title":"Eur Heart J"},{"issue":"2","key":"1923_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/2042098616673990","volume":"8","author":"V Russo","year":"2017","unstructured":"Russo V, Rago A, Proietti R et al (2017) Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence. Ther Adv Drug Saf 8(2):67\u201375","journal-title":"Ther Adv Drug Saf"},{"issue":"20","key":"1923_CR14","first-page":"3961","volume":"19","author":"V Russo","year":"2015","unstructured":"Russo V, Bianchi V, Cavallaro C et al (2015) Efficacy and safety of dabigatran in a \"real-life\" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry. Eur Rev Med Pharmacol Sci 19(20):3961\u20133967","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9586","key":"1923_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","volume":"370","author":"J Mant","year":"2007","unstructured":"Mant J, Hobbs FD, Fletcher K et al (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370(9586):493\u2013503","journal-title":"Lancet"},{"issue":"8","key":"1923_CR16","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1001\/jamainternmed.2016.3057","volume":"176","author":"HA Kooistra","year":"2016","unstructured":"Kooistra HA, Calf AH, Piersma-Wichers M et al (2016) Risk of bleeding and thrombosis in patients 70 years or older using vitamin K antagonists. JAMA Intern Med 176(8):1176\u20131183","journal-title":"JAMA Intern Med"},{"issue":"8","key":"1923_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K et al (2014) Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 129(8):837\u2013847","journal-title":"Circulation"},{"issue":"7","key":"1923_CR18","doi-asserted-by":"publisher","first-page":"e005657","DOI":"10.1161\/JAHA.117.005657","volume":"6","author":"G Patti","year":"2017","unstructured":"Patti G, Lucerna M, Pecen L et al (2017) Thromboembolic risk, bleeding outcomes and effect of different antithrombotic strategies in very elderly patients with atrial fibrillation: a sub-analysis from the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation). J Am Heart Assoc 6(7):e005657","journal-title":"J Am Heart Assoc"},{"key":"1923_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.amjmed.2018.12.036","volume":"132","author":"G Patti","year":"2019","unstructured":"Patti G, Pecen L, Lucerna M et al (2019) Net Clinical benefit of non-vitamin K antagonist vs vitamin k antagonist anticoagulants in elderly patients with atrial fibrillation. Am J Med 132:749\u2013757","journal-title":"Am J Med"},{"key":"1923_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijcard.2019.01.071","volume":"281","author":"M Giustozzi","year":"2019","unstructured":"Giustozzi M, Vedovati MC, Verso M et al (2019) Patients aged 90years or older with atrial fibrillation treated with oral anticoagulants: a multicentre observational study. Int J Cardiol 281:56\u201361","journal-title":"Int J Cardiol"},{"issue":"10","key":"1923_CR21","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/europace\/eux316","volume":"20","author":"M Ruiz Ortiz","year":"2018","unstructured":"Ruiz Ortiz M, Muniz J, Rana Miguez P et al (2018) Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry. Europace 20(10):1577\u20131583","journal-title":"Europace"},{"issue":"5","key":"1923_CR22","doi-asserted-by":"publisher","first-page":"e002758","DOI":"10.1136\/bmjopen-2013-002758","volume":"3","author":"R Sorensen","year":"2013","unstructured":"Sorensen R, Gislason G, Torp-Pedersen C et al (2013) Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study. BMJ open 3(5):e002758","journal-title":"BMJ open"},{"issue":"2","key":"1923_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11239-016-1435-3","volume":"43","author":"M Howard","year":"2017","unstructured":"Howard M, Lipshutz A, Roess B et al (2017) Identification of risk factors for inappropriate and suboptimal initiation of direct oral anticoagulants. J Thromb Thrombolysis 43(2):149\u2013156","journal-title":"J Thromb Thrombolysis"},{"issue":"7","key":"1923_CR24","first-page":"566","volume":"13","author":"CH Kwon","year":"2016","unstructured":"Kwon CH, Kim M, Kim J, Nam GB, Choi KJ, Kim YH (2016) Real-world comparison of non-vitamin K antagonist oral anticoagulants and warfarin in Asian octogenarian patients with atrial fibrillation. J Geriatr Cardiol 13(7):566\u2013572","journal-title":"J Geriatr Cardiol"},{"issue":"1","key":"1923_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1161\/CIRCULATIONAHA.118.037670","volume":"139","author":"TF Chao","year":"2019","unstructured":"Chao TF, Lip GYH, Chen SA (2019) Response by Chao et al to Letter Regarding Article, \"Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study\". Circulation 139(1):146\u2013147","journal-title":"Circulation"},{"issue":"1","key":"1923_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/CIRCULATIONAHA.117.031658","volume":"138","author":"TF Chao","year":"2018","unstructured":"Chao TF, Liu CJ, Lin YJ et al (2018) Oral anticoagulation in very elderly patients with atrial fibrillation: a nationwide cohort study. Circulation 138(1):37\u201347","journal-title":"Circulation"},{"issue":"9921","key":"1923_CR27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383(9921):955\u2013962","journal-title":"Lancet"},{"issue":"15","key":"1923_CR28","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1182\/blood-2014-07-590323","volume":"124","author":"C Chai-Adisaksopha","year":"2014","unstructured":"Chai-Adisaksopha C, Crowther M, Isayama T, Lim W (2014) The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis. Blood 124(15):2450\u20132458","journal-title":"Blood"},{"issue":"2","key":"1923_CR29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s11239-013-1048-z","volume":"38","author":"A Amin","year":"2014","unstructured":"Amin A, Deitelzweig S, Jing Y et al (2014) Estimation of the impact of warfarin's time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials. J Thromb Thrombolysis 38(2):150\u2013159","journal-title":"J Thromb Thrombolysis"},{"issue":"9","key":"1923_CR30","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1586\/14779072.2015.1071665","volume":"13","author":"GY Lip","year":"2015","unstructured":"Lip GY (2015) Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillation. Expert Rev Cardiovasc Ther 13(9):963\u2013965","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"1923_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jacc.2018.04.063","volume":"72","author":"AP Kent","year":"2018","unstructured":"Kent AP, Brueckmann M, Fraessdorf M et al (2018) Concomitant oral anticoagulant and nonsteroidal anti-inflammatory drug therapy in patients with atrial fibrillation. J Am Coll Cardiol 72(3):255\u2013267","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1923_CR32","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1105594","volume":"367","author":"JB Olesen","year":"2012","unstructured":"Olesen JB, Lip GY, Kamper AL et al (2012) Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 367(7):625\u2013635","journal-title":"N Engl J Med"},{"issue":"9","key":"1923_CR33","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.amjmed.2017.04.015","volume":"130","author":"J Fanikos","year":"2017","unstructured":"Fanikos J, Burnett AE, Mahan CE, Dobesh PP (2017) Renal function considerations for stroke prevention in atrial fibrillation. Am J Med 130(9):1015\u20131023","journal-title":"Am J Med"},{"issue":"11","key":"1923_CR34","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.2215\/CJN.02400311","volume":"6","author":"RG Hart","year":"2011","unstructured":"Hart RG, Pearce LA, Asinger RW, Herzog CA (2011) Warfarin in atrial fibrillation patients with moderate chronic kidney disease. Clin J Am Soc Nephrol 6(11):2599\u20132604","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01923-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-019-01923-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01923-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T23:25:20Z","timestamp":1596497120000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-019-01923-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1923"],"URL":"https:\/\/doi.org\/10.1007\/s11239-019-01923-9","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"type":"print","value":"0929-5305"},{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2019,8,5]]},"assertion":[{"value":"5 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}